The HPV16-Positive Head and Neck Squamous Cell Carcinoma Market has established itself as a revolutionary force in modern oncology, characterized by distinct viral-driven pathogenesis and unprecedented therapeutic opportunities. This specialized cancer category, primarily initiated by human papillomavirus type 16 infections, exhibits remarkable biological distinctions from...